Generation of a Genome Scale Lentiviral Vector Library for EF1α Promoter-Driven Expression of Human ORFs and Identification of Human Genes Affecting Viral Titer

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Škalamera, Dubravka ^a   Dahmer, Mareike ^a   Purdon, Amy S ^a,b   Wilson, Benjamin M ^a   Ranall, Max V ^a   Blumenthal, Antje ^a   Gabrielli, Brian ^a   Gonda, Thomas J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MATER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; ELONGATION FACTOR 1ALPHA; LENTIVIRUS VECTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 7; OPSIN; PROTEIN BCL 2; PROTEIN S 100; RIBOSOME PROTEIN; TETRATRICOPEPTIDE REPEAT PROTEIN;

ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE EXPRESSION; GENE IDENTIFICATION; GENE LIBRARY; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; INTERNAL RIBOSOME ENTRY SITE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROMOTER REGION; PROTEIN MOTIF; SUPERNATANT; VIRUS GENOME; VIRUS TITRATION;

CELL SURVIVAL; CYTOMEGALOVIRUS; FLUORESCENCE; GENE EXPRESSION; GENE LIBRARY; GENETIC VECTORS; GENOME, HUMAN; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LENTIVIRUS; OPEN READING FRAMES; PEPTIDE ELONGATION FACTOR 1; PROMOTER REGIONS, GENETIC; TRANSDUCTION, GENETIC; TRANSFECTION; VIRAL LOAD;

LENTIVIRUS; MAMMALIA;

EID: 84871221001     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051733     Document Type: Article

References (59)

1. Prelich G, (2012) Gene overexpression: uses, mechanisms, and interpretation. Genetics 190: 841-854.
2. Skalamera D, Ranall MV, Wilson BM, Leo P, Purdon AS, et al. (2011) A high-throughput platform for lentiviral overexpression screening of the human ORFeome. PloS one 6: e20057.
3. Yang X, Boehm JS, Salehi-Ashtiani K, Hao T, Shen Y, et al. (2011) A public genome-scale lentiviral expression library of human ORFs. Nature methods 8: 659-661.
4. Rual JF, Hirozane-Kishikawa T, Hao T, Bertin N, Li S, et al. (2004) Human ORFeome version 1.1: a platform for reverse proteomics. Genome Res 14: 2128-2135.
5. Lamesch P, Li N, Milstein S, Fan C, Hao T, et al. (2007) hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes. Genomics 89: 307-315.
6. Bechtel S, Rosenfelder H, Duda A, Schmidt CP, Ernst U, et al. (2007) The full-ORF clone resource of the German cDNA Consortium. BMC Genomics 8: 399.
7. Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, et al. (2002) Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proceedings of the National Academy of Sciences of the United States of America 99: 16899-16903.
8. Escors D, Breckpot K, (2010) Lentiviral vectors in gene therapy: their current status and future potential. Arch Immunol Ther Exp (Warsz) 58: 107-119.
9. Matrai J, Chuah MK, VandenDriessche T, (2010) Recent advances in lentiviral vector development and applications. Molecular therapy: the journal of the American Society of Gene Therapy 18: 477-490.
10. Ramezani A, Hawley RG (2002) Overview of the HIV-1 Lentiviral Vector System. Current protocols. In: Ausubel FM, et al., editors. Molecular Biology. Chapter 16: Unit 16 21.
11. Logan AC, Nightingale SJ, Haas DL, Cho GJ, Pepper KA, et al. (2004) Factors influencing the titer and infectivity of lentiviral vectors. Human gene therapy 15: 976-988.
12. Delenda C, (2004) Lentiviral vectors: optimization of packaging, transduction and gene expression. The journal of gene medicine 6Suppl 1: S125-138.
13. Mao G, Marotta F, Yu J, Zhou L, Yu Y, et al. (2008) DNA context and promoter activity affect gene expression in lentiviral vectors. Acta bio-medica: Atenei Parmensis 79: 192-196.
14. Bailey SN, Ali SM, Carpenter AE, Higgins CO, Sabatini DM, (2006) Microarrays of lentiviruses for gene function screens in immortalized and primary cells. Nat Methods 3: 117-122.
15. Wan D, Gong Y, Qin W, Zhang P, Li J, et al. (2004) Large-scale cDNA transfection screening for genes related to cancer development and progression. Proc Natl Acad Sci U S A 101: 15724-15729.
16. Palmer EL, Miller AD, Freeman TC, (2006) Identification and characterisation of human apoptosis inducing proteins using cell-based transfection microarrays and expression analysis. BMC genomics 7: 145.
17. Kamensek U, Sersa G, Vidic S, Tevz G, Kranjc S, et al. (2011) Irradiation, cisplatin, and 5-azacytidine upregulate cytomegalovirus promoter in tumors and muscles: implementation of non-invasive fluorescence imaging. Mol Imaging Biol 13: 43-52.
18. Duan B, Cheng L, Gao Y, Yin FX, Su GH, et al. (2012) Silencing of fat-1 transgene expression in sheep may result from hypermethylation of its driven cytomegalovirus (CMV) promoter. Theriogenology 78: 793-802.
19. Mehta AK, Majumdar SS, Alam P, Gulati N, Brahmachari V, (2009) Epigenetic regulation of cytomegalovirus major immediate-early promoter activity in transgenic mice. Gene 428: 20-24.
20. Choi KH, Basma H, Singh J, Cheng PW, (2005) Activation of CMV promoter-controlled glycosyltransferase and beta-galactosidase glycogenes by butyrate, tricostatin A, and 5-aza-2′-deoxycytidine. Glycoconj J 22: 63-69.
21. Tokushige K, Moradpour D, Wakita T, Geissler M, Hayashi N, et al. (1997) Comparison between cytomegalovirus promoter and elongation factor-1 alpha promoter-driven constructs in the establishment of cell lines expressing hepatitis C virus core protein. Journal of virological methods 64: 73-80.
22. Almeciga-Diaz CJ, Rueda-Paramo MA, Espejo AJ, Echeverri OY, Montano A, et al. (2009) Effect of elongation factor 1alpha promoter and SUMF1 over in vitro expression of N-acetylgalactosamine-6-sulfate sulfatase. Molecular biology reports 36: 1863-1870.
23. Qin JY, Zhang L, Clift KL, Hulur I, Xiang AP, et al. (2010) Systematic comparison of constitutive promoters and the doxycycline-inducible promoter. PloS one 5: e10611.
24. Thomas P, Smart TG, (2005) HEK293 cell line: a vehicle for the expression of recombinant proteins. Journal of pharmacological and toxicological methods 51: 187-200.
25. Palmer E, Freeman TC, (2011) Large-scale cell-based microarrays and their use with HEK293T cells and downstream apoptotic assays. Methods in molecular biology 706: 27-40.
26. Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, et al. (2006) A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124: 1283-1298.
27. Ansorge S, Lanthier S, Transfiguracion J, Durocher Y, Henry O, et al. (2009) Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures. The journal of gene medicine 11: 868-876.
28. Barry SC, Harder B, Brzezinski M, Flint LY, Seppen J, et al. (2001) Lentivirus vectors encoding both central polypurine tract and posttranscriptional regulatory element provide enhanced transduction and transgene expression. Hum Gene Ther 12: 1103-1108.
29. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, et al. (1998) A third-generation lentivirus vector with a conditional packaging system. Journal of virology 72: 8463-8471.
30. Haferkamp S, Scurr LL, Becker TM, Frausto M, Kefford RF, et al. (2009) Oncogene-induced senescence does not require the p16(INK4a) or p14ARF melanoma tumor suppressors. The Journal of investigative dermatology 129: 1983-1991.
31. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols 4: 44-57.
32. Devitt G, Thomas M, Klibanov AM, Pfeiffer T, Bosch V, (2007) Optimized protocol for the large scale production of HIV pseudovirions by transient transfection of HEK293T cells with linear fully deacylated polyethylenimine. Journal of virological methods 146: 298-304.
33. Kumar M, Keller B, Makalou N, Sutton RE, (2001) Systematic determination of the packaging limit of lentiviral vectors. Human gene therapy 12: 1893-1905.
34. Van de Parre TJL, Martinet W, Schrijvers DM, Herman AG, De Meyer GRY, (2005) MRNA but not plasmid DNA is efficiently transfected in murine J774A.1 macrophages. Biochemical and biophysical research communications 327: 356-360.
35. Dokka S, Toledo D, Shi XL, Ye JP, Rojanasakul Y, (2000) High-efficiency gene transfection of macrophages by lipoplexes. International Journal of Pharmaceutics 206: 97-104.
36. Geraerts M, Willems S, Baekelandt V, Debyser Z, Gijsbers R, (2006) Comparison of lentiviral vector titration methods. BMC Biotechnol 6: 34.
37. Mizuguchi H, Xu Z, Ishii-Watabe A, Uchida E, Hayakawa T, (2000) IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 1: 376-382.
38. Patzel V, Sczakiel G, (1997) The hepatitis B virus posttranscriptional regulatory element contains a highly stable RNA secondary structure. Biochemical and biophysical research communications 231: 864-867.
39. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, et al. (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science 319: 921-926.
40. Fu W, Sanders-Beer BE, Katz KS, Maglott DR, Pruitt KD, et al. (2009) Human immunodeficiency virus type 1, human protein interaction database at NCBI. Nucleic acids research 37: D417-422.
41. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, et al. (2008) Genome-scale RNAi screen for host factors required for HIV replication. Cell host & microbe 4: 495-504.
42. Nomura N, Zhao MJ, Nagase T, Maekawa T, Ishizaki R, et al. (1991) HIV-EP2, a new member of the gene family encoding the human immunodeficiency virus type 1 enhancer-binding protein. Comparison with HIV-EP1/PRDII-BF1/MBP-1. The Journal of biological chemistry 266: 8590-8594.
43. Sudo T, Ozawa K, Soeda EI, Nomura N, Ishii S, (1992) Mapping of the human gene for the human immunodeficiency virus type 1 enhancer binding protein HIV-EP2 to chromosome 6q23-q24. Genomics 12: 167-170.
44. Chenal A, Vendrely C, Vitrac H, Karst JC, Gonneaud A, et al. (2012) Amyloid fibrils formed by the programmed cell death regulator Bcl-xL. Journal of molecular biology 415: 584-599.
45. Lamarca V, Marzo I, Sanz-Clemente A, Carrodeguas JA, (2008) Exposure of any of two proapoptotic domains of presenilin 1-associated protein/mitochondrial carrier homolog 1 on the surface of mitochondria is sufficient for induction of apoptosis in a Bax/Bak-independent manner. European journal of cell biology 87: 325-334.
46. Schuller M, Jenne D, Voltz R, (2005) The human PNMA family: novel neuronal proteins implicated in paraneoplastic neurological disease. Journal of neuroimmunology 169: 172-176.
47. Chen HL, D'Mello SR, (2010) Induction of neuronal cell death by paraneoplastic Ma1 antigen. Journal of neuroscience research 88: 3508-3519.
48. Schinzel A, Kaufmann T, Borner C, (2004) Bcl-2 family members: integrators of survival and death signals in physiology and pathology [corrected]. Biochimica et biophysica acta 1644: 95-105.
49. Youle RJ, Strasser A, (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nature reviews Molecular cell biology 9: 47-59.
50. Marcotte EM, Tsechansky M, (2009) Disorder, promiscuity, and toxic partnerships. Cell 138: 16-18.
51. Vavouri T, Semple JI, Garcia-Verdugo R, Lehner B, (2009) Intrinsic protein disorder and interaction promiscuity are widely associated with dosage sensitivity. Cell 138: 198-208.
52. Turkish AR, Henneberry AL, Cromley D, Padamsee M, Oelkers P, et al. (2005) Identification of two novel human acyl-CoA wax alcohol acyltransferases: members of the diacylglycerol acyltransferase 2 (DGAT2) gene superfamily. The Journal of biological chemistry 280: 14755-14764.
53. Tsurugi K, Collatz E, Todokoro K, Wool IG, (1977) Isolation of eukaryotic ribosomal proteins. Purification and characterization of 60 S ribosomal subunit proteins L3, L6, L7′, L8, L10, L15, L17, L18, L19, L23′, L25, L27′, L28, L29, L31, L32, L34, L35, L36, L36′, and L37′. The Journal of biological chemistry 252: 3961-3969.
54. Hendrickson SL, Lautenberger JA, Chinn LW, Malasky M, Sezgin E, et al. (2010) Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. PloS one 5: e12862.
55. Prus W, Filipek A, (2011) S100A6 mediates nuclear translocation of Sgt1: a heat shock-regulated protein. Amino acids 41: 781-787.
56. Ching YP, Zhou HJ, Yuan JG, Qiang BQ, Kung HF, et al. (2002) Identification and characterization of FTSJ2, a novel human nucleolar protein homologous to bacterial ribosomal RNA methyltransferase. Genomics 79: 2-6.
57. Yudin Y, Rohacs T, (2012) Regulation of TRPM8 channel activity. Molecular and cellular endocrinology 353: 68-74.
58. Haferkamp S, Becker TM, Scurr LL, Kefford RF, Rizos H, (2008) p16INK4a-induced senescence is disabled by melanoma-associated mutations. Aging cell 7: 733-745.
59. Blumenthal A, Kobayashi T, Pierini LM, Banaei N, Ernst JD, et al. (2009) RP105 facilitates macrophage activation by Mycobacterium tuberculosis lipoproteins. Cell host & microbe 5: 35-46.